MindMed (NASDAQ:MNMD, NEO:MMED) shares soared more than 26% higher before Thursday’s opening bell on news...
14.13 Thu 07 Mar 2024
Proactive Research analyst Ed Stacey talks to Katie Pilbeam about his research on Mydecine Innovations Group which is a biotech and life sciences company. The firm develop and commercialise new therapies for mental health and other conditions. In recent months the company has achieved...